Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease

Higher Baseline Serum Irisin Decreases Risk for Body Mass Index Increment in Chinese Populations: A 3.2-Year Cohort Study

(2019) Ruoyi Liu et al.   Diabetes Therapy

A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism

(2019) Andrea Palermo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Mortality in Patients with Endogenous Cushing’s Syndrome

(2018) Pedram Javanmard et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Sarcopenia – Endocrinological and Neurological Aspects

(2018) Michaela Stangl et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Circulating irisin levels in children with growth hormone (GH) deficiency before and after 1 year of GH treatment

(2018) Alessandro Ciresi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry

(2017) Christina M Berr et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis

(2017) D. Pérez-Sotelo et al.   Scientific Reports

Glucocorticoid receptor positively regulates transcription of FNDC5 in the liver

(2017) Hyoung Kyu Kim et al.   Scientific Reports

Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice

(2017) Graziana Colaianni et al.   Scientific Reports

FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice

(2016) Tong-Yan Liu et al.   DIABETES

Zależne od czasu zmiany stężenia irisiny u pacjentów z jawną niedoczynnością tarczycy

(2016) Ariadna Zybek-Kocik et al.   Endokrynologia Polska

Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis

(2016) X.-l. Du et al.   HORMONE AND METABOLIC RESEARCH

Insulin resistance and sarcopenia: mechanistic links between common co-morbidities

(2016) Mark E Cleasby et al.   JOURNAL OF ENDOCRINOLOGY

Complications of Cushing's syndrome: state of the art

(2016) Rosario Pivonello et al.   Lancet Diabetes & Endocrinology

Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction

(2016) Yuzhu Zhang et al.   PLoS One

Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity

(2015) Andrea Palermo et al.   CLINICAL ENDOCRINOLOGY

Irisin: A true, circulating hormone

(2015) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The myokine irisin increases cortical bone mass

(2015) Graziana Colaianni et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Irisin and FGF21 Are Cold-Induced Endocrine Activators of Brown Fat Function in Humans

(2014) Paul Lee et al.   Cell Metabolism

Implication of Circulating Irisin Levels with Brown Adipose Tissue and Sarcopenia in Humans

(2014) Hae Yoon Choi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Steroid myopathy: Some unresolved issues

(2014) M. A. Minetto et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months

(2014) A. D. Anastasilakis et al.   OSTEOPOROSIS INTERNATIONAL

Three new players in energy regulation: Preptin, adropin and irisin

(2014) Suleyman Aydin   PEPTIDES

Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index

(2014) María Pardo et al.   International Journal of Endocrinology

Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling

(2013) Y. Zhang et al.   DIABETES

Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?

(2013) Carla Giordano et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Mechanisms regulating skeletal muscle growth and atrophy

(2013) Stefano Schiaffino et al.   FEBS Journal

Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome

(2013) Kyung Hee Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower circulating irisin is associated with type 2 diabetes mellitus

(2013) Jian-Jun Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Are skeletal muscleFNDC5gene expression and irisin release regulated by exercise and related to health?

(2013) Satu Pekkala et al.   JOURNAL OF PHYSIOLOGY-LONDON

Irisin in patients with nonalcoholic fatty liver disease

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients

(2013) Ana B. Crujeiras et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

(2012) Joo Young Huh et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Is irisin a human exercise gene?

(2012) James A. Timmons et al.   NATURE

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index

(2012) Andreas Stengel et al.   PEPTIDES

Mortality and morbidity in Cushing’s syndrome in New Zealand

(2011) Mark J. Bolland et al.   CLINICAL ENDOCRINOLOGY

Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

(2008) K. M. Utzschneider et al.   DIABETES CARE

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

(2008) Lynnette K. Nieman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM